Schiele, François http://orcid.org/0000-0003-4974-6551
Pérez de Isla, Leopoldo
Arca, Marcello
Vlachopoulos, Charalambos
Article History
Accepted: 11 August 2021
First Online: 22 September 2021
Declarations
:
: The open access fee for this article was funded by Servier.
: Francois Schiele has received personal fees from Amgen, Astra Zeneca, Bayer, BMS, MSD, Pfizer, and Sanofi outside the submitted work. Leopoldo Pérez de Isla has received research grants, fees as advisor, and lecturing fees from Servier, Novartis, Amgen, Amryt, Daiichi-Sankyo, Pfizer, Sanofi, Menarini, and Almirall. Marcello Arca has received research grant support and lecturing fees from Amgen, Amryt, IONIS/Akcea Therapeutics, Daiichi-Sankyo, Novartis, Pfizer, Regeneron, and Sanofi. Charalambos Vlachopoulos has received research grant support and lecturing fees from Amgen, Bayer, Boehringer Ingelheim, Mylan, Sanofi, and Servier.
: Not applicable, as this is a review article.
: Not applicable.
: Not applicable.
: All authors made a substantial contribution to the concept or design of the work or acquisition, analysis or interpretation of data. All authors drafted the article or revised it critically for important intellectual content, and approved the version to be published. All authors participated sufficiently in the work to take public responsibility for appropriate portions of the content.